Summary
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
According to APO Research, the global Bacteriophage market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Bacteriophage market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Bacteriophage market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and Pherecydes Pharma, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Bacteriophage, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Bacteriophage, also provides the value of main regions and countries. Of the upcoming market potential for Bacteriophage, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bacteriophage revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Bacteriophage market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Bacteriophage company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Bacteriophage Segment by Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Bacteriophage Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Bacteriophage status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Bacteriophage key companies, revenue, market share, and recent developments.
3. To split the Bacteriophage breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Bacteriophage market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Bacteriophage significant trends, drivers, influence factors in global and regions.
6. To analyze Bacteriophage competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacteriophage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacteriophage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacteriophage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bacteriophage industry.
Chapter 3: Detailed analysis of Bacteriophage company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Bacteriophage in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Bacteriophage in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
- Market Overview
- Product Definition
- Global Bacteriophage Market Size, 2020 VS 2024 VS 2031
- Global Bacteriophage Market Size (2020-2031)
- Assumptions and Limitations
- Study Goals and Objectives
- Bacteriophage Market Dynamics
- Bacteriophage Industry Trends
- Bacteriophage Industry Drivers
- Bacteriophage Industry Opportunities and Challenges
- Bacteriophage Industry Restraints
- Bacteriophage Market by Company
- Global Bacteriophage Company Revenue Ranking in 2024
- Global Bacteriophage Revenue by Company (2020-2025)
- Global Bacteriophage Company Ranking (2023-2025)
- Global Bacteriophage Company Manufacturing Base and Headquarters
- Global Bacteriophage Company Product Type and Application
- Global Bacteriophage Company Establishment Date
- Market Competitive Analysis
- Global Bacteriophage Market Concentration Ratio (CR5 and HHI)
- Global Top 5 and 10 Company Market Share by Revenue in 2024
- 2024 Bacteriophage Tier 1, Tier 2, and Tier 3 Companies
- Mergers and Acquisitions Expansion
- Bacteriophage Market by Type
- Bacteriophage Type Introduction
- DsDNA Bacteriophage
- SsDNA Bacteriophage
- SsRNA Bacteriophage
- Others
- Global Bacteriophage Sales Value by Type
- Global Bacteriophage Sales Value by Type (2020 VS 2024 VS 2031)
- Global Bacteriophage Sales Value by Type (2020-2031)
- Global Bacteriophage Sales Value Share by Type (2020-2031)
- Bacteriophage Type Introduction
- Bacteriophage Market by Application
- Bacteriophage Application Introduction
- Animal Health
- Aquaculture
- Agriculture
- Food Industry
- Human Health
- Others
- Global Bacteriophage Sales Value by Application
- Global Bacteriophage Sales Value by Application (2020 VS 2024 VS 2031)
- Global Bacteriophage Sales Value by Application (2020-2031)
- Global Bacteriophage Sales Value Share by Application (2020-2031)
- Bacteriophage Application Introduction
- Bacteriophage Regional Value Analysis
- Global Bacteriophage Sales Value by Region: 2020 VS 2024 VS 2031
- Global Bacteriophage Sales Value by Region (2020-2031)
- Global Bacteriophage Sales Value by Region: 2020-2025
- Global Bacteriophage Sales Value by Region (2026-2031)
- North America
- North America Bacteriophage Sales Value (2020-2031)
- North America Bacteriophage Sales Value Share by Country, 2024 VS 2031
- Europe
- Europe Bacteriophage Sales Value (2020-2031)
- Europe Bacteriophage Sales Value Share by Country, 2024 VS 2031
- Asia-Pacific
- Asia-Pacific Bacteriophage Sales Value (2020-2031)
- Asia-Pacific Bacteriophage Sales Value Share by Country, 2024 VS 2031
- South America
- South America Bacteriophage Sales Value (2020-2031)
- South America Bacteriophage Sales Value Share by Country, 2024 VS 2031
- Middle East & Africa
- Middle East & Africa Bacteriophage Sales Value (2020-2031)
- Middle East & Africa Bacteriophage Sales Value Share by Country, 2024 VS 2031
- Bacteriophage Country-level Value Analysis
- Global Bacteriophage Sales Value by Country: 2020 VS 2024 VS 2031
- Global Bacteriophage Sales Value by Country (2020-2031)
- Global Bacteriophage Sales Value by Country (2020-2025)
- Global Bacteriophage Sales Value by Country (2026-2031)
- USA
- USA Bacteriophage Sales Value Growth Rate (2020-2031)
- USA Bacteriophage Sales Value Share by Type, 2024 VS 2031
- USA Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Canada
- Canada Bacteriophage Sales Value Growth Rate (2020-2031)
- Canada Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Canada Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Mexico
- Mexico Bacteriophage Sales Value Growth Rate (2020-2031)
- Mexico Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Mexico Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Germany
- Germany Bacteriophage Sales Value Growth Rate (2020-2031)
- Germany Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Germany Bacteriophage Sales Value Share by Application, 2024 VS 2031
- France
- France Bacteriophage Sales Value Growth Rate (2020-2031)
- France Bacteriophage Sales Value Share by Type, 2024 VS 2031
- France Bacteriophage Sales Value Share by Application, 2024 VS 2031
- U.K.
- U.K. Bacteriophage Sales Value Growth Rate (2020-2031)
- U.K. Bacteriophage Sales Value Share by Type, 2024 VS 2031
- U.K. Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Italy
- Italy Bacteriophage Sales Value Growth Rate (2020-2031)
- Italy Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Italy Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Spain
- Spain Bacteriophage Sales Value Growth Rate (2020-2031)
- Spain Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Spain Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Russia
- Russia Bacteriophage Sales Value Growth Rate (2020-2031)
- Russia Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Russia Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Netherlands
- Netherlands Bacteriophage Sales Value Growth Rate (2020-2031)
- Netherlands Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Netherlands Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Nordic Countries
- Nordic Countries Bacteriophage Sales Value Growth Rate (2020-2031)
- Nordic Countries Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Nordic Countries Bacteriophage Sales Value Share by Application, 2024 VS 2031
- China
- China Bacteriophage Sales Value Growth Rate (2020-2031)
- China Bacteriophage Sales Value Share by Type, 2024 VS 2031
- China Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Japan
- Japan Bacteriophage Sales Value Growth Rate (2020-2031)
- Japan Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Japan Bacteriophage Sales Value Share by Application, 2024 VS 2031
- South Korea
- South Korea Bacteriophage Sales Value Growth Rate (2020-2031)
- South Korea Bacteriophage Sales Value Share by Type, 2024 VS 2031
- South Korea Bacteriophage Sales Value Share by Application, 2024 VS 2031
- India
- India Bacteriophage Sales Value Growth Rate (2020-2031)
- India Bacteriophage Sales Value Share by Type, 2024 VS 2031
- India Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Australia
- Australia Bacteriophage Sales Value Growth Rate (2020-2031)
- Australia Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Australia Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Southeast Asia
- Southeast Asia Bacteriophage Sales Value Growth Rate (2020-2031)
- Southeast Asia Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Southeast Asia Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Brazil
- Brazil Bacteriophage Sales Value Growth Rate (2020-2031)
- Brazil Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Brazil Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Argentina
- Argentina Bacteriophage Sales Value Growth Rate (2020-2031)
- Argentina Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Argentina Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Chile
- Chile Bacteriophage Sales Value Growth Rate (2020-2031)
- Chile Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Chile Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Colombia
- Colombia Bacteriophage Sales Value Growth Rate (2020-2031)
- Colombia Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Colombia Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Peru
- Peru Bacteriophage Sales Value Growth Rate (2020-2031)
- Peru Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Peru Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Saudi Arabia
- Saudi Arabia Bacteriophage Sales Value Growth Rate (2020-2031)
- Saudi Arabia Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Saudi Arabia Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Israel
- Israel Bacteriophage Sales Value Growth Rate (2020-2031)
- Israel Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Israel Bacteriophage Sales Value Share by Application, 2024 VS 2031
- UAE
- UAE Bacteriophage Sales Value Growth Rate (2020-2031)
- UAE Bacteriophage Sales Value Share by Type, 2024 VS 2031
- UAE Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Turkey
- Turkey Bacteriophage Sales Value Growth Rate (2020-2031)
- Turkey Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Turkey Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Iran
- Iran Bacteriophage Sales Value Growth Rate (2020-2031)
- Iran Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Iran Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Egypt
- Egypt Bacteriophage Sales Value Growth Rate (2020-2031)
- Egypt Bacteriophage Sales Value Share by Type, 2024 VS 2031
- Egypt Bacteriophage Sales Value Share by Application, 2024 VS 2031
- Company Profiles
- NPO Microgen
- NPO Microgen Comapny Information
- NPO Microgen Business Overview
- NPO Microgen Bacteriophage Revenue and Gross Margin (2020-2025)
- NPO Microgen Bacteriophage Product Portfolio
- NPO Microgen Recent Developments
- Proteon Pharmaceuticals
- Proteon Pharmaceuticals Comapny Information
- Proteon Pharmaceuticals Business Overview
- Proteon Pharmaceuticals Bacteriophage Revenue and Gross Margin (2020-2025)
- Proteon Pharmaceuticals Bacteriophage Product Portfolio
- Proteon Pharmaceuticals Recent Developments
- Phagelux
- Phagelux Comapny Information
- Phagelux Business Overview
- Phagelux Bacteriophage Revenue and Gross Margin (2020-2025)
- Phagelux Bacteriophage Product Portfolio
- Phagelux Recent Developments
- Intralytix
- Intralytix Comapny Information
- Intralytix Business Overview
- Intralytix Bacteriophage Revenue and Gross Margin (2020-2025)
- Intralytix Bacteriophage Product Portfolio
- Intralytix Recent Developments
- Micreos
- Micreos Comapny Information
- Micreos Business Overview
- Micreos Bacteriophage Revenue and Gross Margin (2020-2025)
- Micreos Bacteriophage Product Portfolio
- Micreos Recent Developments
- Eliava BioPreparations
- Eliava BioPreparations Comapny Information
- Eliava BioPreparations Business Overview
- Eliava BioPreparations Bacteriophage Revenue and Gross Margin (2020-2025)
- Eliava BioPreparations Bacteriophage Product Portfolio
- Eliava BioPreparations Recent Developments
- Locus Biosciences,Inc
- Locus Biosciences,Inc Comapny Information
- Locus Biosciences,Inc Business Overview
- Locus Biosciences,Inc Bacteriophage Revenue and Gross Margin (2020-2025)
- Locus Biosciences,Inc Bacteriophage Product Portfolio
- Locus Biosciences,Inc Recent Developments
- Pharmex Group,LLC
- Pharmex Group,LLC Comapny Information
- Pharmex Group,LLC Business Overview
- Pharmex Group,LLC Bacteriophage Revenue and Gross Margin (2020-2025)
- Pharmex Group,LLC Bacteriophage Product Portfolio
- Pharmex Group,LLC Recent Developments
- Pherecydes Pharma
- Pherecydes Pharma Comapny Information
- Pherecydes Pharma Business Overview
- Pherecydes Pharma Bacteriophage Revenue and Gross Margin (2020-2025)
- Pherecydes Pharma Bacteriophage Product Portfolio
- Pherecydes Pharma Recent Developments
- APS Biocontrol Ltd. (APS)
- APS Biocontrol Ltd. (APS) Comapny Information
- APS Biocontrol Ltd. (APS) Business Overview
- APS Biocontrol Ltd. (APS) Bacteriophage Revenue and Gross Margin (2020-2025)
- APS Biocontrol Ltd. (APS) Bacteriophage Product Portfolio
- APS Biocontrol Ltd. (APS) Recent Developments
- Qingdao Phagepharm Bio-tech
- Qingdao Phagepharm Bio-tech Comapny Information
- Qingdao Phagepharm Bio-tech Business Overview
- Qingdao Phagepharm Bio-tech Bacteriophage Revenue and Gross Margin (2020-2025)
- Qingdao Phagepharm Bio-tech Bacteriophage Product Portfolio
- Qingdao Phagepharm Bio-tech Recent Developments
- Fixed-Phage Limited
- Fixed-Phage Limited Comapny Information
- Fixed-Phage Limited Business Overview
- Fixed-Phage Limited Bacteriophage Revenue and Gross Margin (2020-2025)
- Fixed-Phage Limited Bacteriophage Product Portfolio
- Fixed-Phage Limited Recent Developments
- Zeptometrix
- Zeptometrix Comapny Information
- Zeptometrix Business Overview
- Zeptometrix Bacteriophage Revenue and Gross Margin (2020-2025)
- Zeptometrix Bacteriophage Product Portfolio
- Zeptometrix Recent Developments
- Phage International, Inc.
- Phage International, Inc. Comapny Information
- Phage International, Inc. Business Overview
- Phage International, Inc. Bacteriophage Revenue and Gross Margin (2020-2025)
- Phage International, Inc. Bacteriophage Product Portfolio
- Phage International, Inc. Recent Developments
- MicroMir
- MicroMir Comapny Information
- MicroMir Business Overview
- MicroMir Bacteriophage Revenue and Gross Margin (2020-2025)
- MicroMir Bacteriophage Product Portfolio
- MicroMir Recent Developments
- iNtODEWORLD, Inc.
- iNtODEWORLD, Inc. Comapny Information
- iNtODEWORLD, Inc. Business Overview
- iNtODEWORLD, Inc. Bacteriophage Revenue and Gross Margin (2020-2025)
- iNtODEWORLD, Inc. Bacteriophage Product Portfolio
- iNtODEWORLD, Inc. Recent Developments
- NEXTBIOTICS
- NEXTBIOTICS Comapny Information
- NEXTBIOTICS Business Overview
- NEXTBIOTICS Bacteriophage Revenue and Gross Margin (2020-2025)
- NEXTBIOTICS Bacteriophage Product Portfolio
- NEXTBIOTICS Recent Developments
- Armata Pharmaceuticals, Inc.
- Armata Pharmaceuticals, Inc. Comapny Information
- Armata Pharmaceuticals, Inc. Business Overview
- Armata Pharmaceuticals, Inc. Bacteriophage Revenue and Gross Margin (2020-2025)
- Armata Pharmaceuticals, Inc. Bacteriophage Product Portfolio
- Armata Pharmaceuticals, Inc. Recent Developments
- Innophage
- Innophage Comapny Information
- Innophage Business Overview
- Innophage Bacteriophage Revenue and Gross Margin (2020-2025)
- Innophage Bacteriophage Product Portfolio
- Innophage Recent Developments
- Adaptive Phage Therapeutics
- Adaptive Phage Therapeutics Comapny Information
- Adaptive Phage Therapeutics Business Overview
- Adaptive Phage Therapeutics Bacteriophage Revenue and Gross Margin (2020-2025)
- Adaptive Phage Therapeutics Bacteriophage Product Portfolio
- Adaptive Phage Therapeutics Recent Developments
- TechnoPhage
- TechnoPhage Comapny Information
- TechnoPhage Business Overview
- TechnoPhage Bacteriophage Revenue and Gross Margin (2020-2025)
- TechnoPhage Bacteriophage Product Portfolio
- TechnoPhage Recent Developments
- NPO Microgen
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
List of Tables
Table 1 | :Bacteriophage Industry Trends |
Table 2 | :Bacteriophage Industry Drivers |
Table 3 | :Bacteriophage Industry Opportunities and Challenges |
Table 4 | :Bacteriophage Industry Restraints |
Table 5 | :Global Bacteriophage Revenue by Company (US$ Million) & (2020-2025) |
Table 6 | :Global Bacteriophage Revenue Share by Company (2020-2025) |
Table 7 | :Global Bacteriophage Company Ranking, (2023-2025) & (US$ Million) |
Table 8 | :Global Bacteriophage Key Company Manufacturing Base & Headquarters |
Table 9 | :Global Bacteriophage Company, Product Type & Application |
Table 10 | :Global Bacteriophage Company Establishment Date |
Table 11 | :Global Company Market Concentration Ratio (CR5 and HHI) |
Table 12 | :Global Bacteriophage by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2024) |
Table 13 | :Mergers & Acquisitions, Expansion |
Table 14 | :Significant Companies of DsDNA Bacteriophage |
Table 15 | :Significant Companies of SsDNA Bacteriophage |
Table 16 | :Significant Companies of SsRNA Bacteriophage |
Table 17 | :Significant Companies of Others |
Table 18 | :Global Bacteriophage Sales Value by Type 2020 VS 2024 VS 2031 (US$ Million) |
Table 19 | :Global Bacteriophage Sales Value by Type (2020-2025) & (US$ Million) |
Table 20 | :Global Bacteriophage Sales Value by Type (2026-2031) & (US$ Million) |
Table 21 | :Global Bacteriophage Sales Value Share by Type (2020-2025) |
Table 22 | :Global Bacteriophage Sales Value Share by Type (2026-2031) |
Table 23 | :Significant Companies of Animal Health |
Table 24 | :Significant Companies of Aquaculture |
Table 25 | :Significant Companies of Agriculture |
Table 26 | :Significant Companies of Food Industry |
Table 27 | :Significant Companies of Human Health |
Table 28 | :Significant Companies of Others |
Table 29 | :Global Bacteriophage Sales Value by Application 2020 VS 2024 VS 2031 (US$ Million) |
Table 30 | :Global Bacteriophage Sales Value by Application (2020-2025) & (US$ Million) |
Table 31 | :Global Bacteriophage Sales Value by Application (2026-2031) & (US$ Million) |
Table 32 | :Global Bacteriophage Sales Value Share by Application (2020-2025) |
Table 33 | :Global Bacteriophage Sales Value Share by Application (2026-2031) |
Table 34 | :Global Bacteriophage Sales Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Table 35 | :Global Bacteriophage Sales Value by Region (2020-2025) & (US$ Million) |
Table 36 | :Global Bacteriophage Sales Value Share by Region (2020-2025) |
Table 37 | :Global Bacteriophage Sales Value by Region (2026-2031) & (US$ Million) |
Table 38 | :Global Bacteriophage Sales Value Share by Region (2026-2031) |
Table 39 | :Global Bacteriophage Sales Value by Country: 2020 VS 2024 VS 2031 (US$ Million) |
Table 40 | :Global Bacteriophage Sales Value by Country (2020-2025) & (US$ Million) |
Table 41 | :Global Bacteriophage Sales Value Market Share by Country (2020-2025) |
Table 42 | :Global Bacteriophage Sales Value by Country (2026-2031) & (US$ Million) |
Table 43 | :Global Bacteriophage Sales Value Market Share by Country (2026-2031) |
Table 44 | :NPO Microgen Company Information |
Table 45 | :NPO Microgen Business Overview |
Table 46 | :NPO Microgen Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 47 | :NPO Microgen Bacteriophage Product Portfolio |
Table 48 | :NPO Microgen Recent Development |
Table 49 | :Proteon Pharmaceuticals Company Information |
Table 50 | :Proteon Pharmaceuticals Business Overview |
Table 51 | :Proteon Pharmaceuticals Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 52 | :Proteon Pharmaceuticals Bacteriophage Product Portfolio |
Table 53 | :Proteon Pharmaceuticals Recent Development |
Table 54 | :Phagelux Company Information |
Table 55 | :Phagelux Business Overview |
Table 56 | :Phagelux Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 57 | :Phagelux Bacteriophage Product Portfolio |
Table 58 | :Phagelux Recent Development |
Table 59 | :Intralytix Company Information |
Table 60 | :Intralytix Business Overview |
Table 61 | :Intralytix Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 62 | :Intralytix Bacteriophage Product Portfolio |
Table 63 | :Intralytix Recent Development |
Table 64 | :Micreos Company Information |
Table 65 | :Micreos Business Overview |
Table 66 | :Micreos Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 67 | :Micreos Bacteriophage Product Portfolio |
Table 68 | :Micreos Recent Development |
Table 69 | :Eliava BioPreparations Company Information |
Table 70 | :Eliava BioPreparations Business Overview |
Table 71 | :Eliava BioPreparations Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 72 | :Eliava BioPreparations Bacteriophage Product Portfolio |
Table 73 | :Eliava BioPreparations Recent Development |
Table 74 | :Locus Biosciences,Inc Company Information |
Table 75 | :Locus Biosciences,Inc Business Overview |
Table 76 | :Locus Biosciences,Inc Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 77 | :Locus Biosciences,Inc Bacteriophage Product Portfolio |
Table 78 | :Locus Biosciences,Inc Recent Development |
Table 79 | :Pharmex Group,LLC Company Information |
Table 80 | :Pharmex Group,LLC Business Overview |
Table 81 | :Pharmex Group,LLC Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 82 | :Pharmex Group,LLC Bacteriophage Product Portfolio |
Table 83 | :Pharmex Group,LLC Recent Development |
Table 84 | :Pherecydes Pharma Company Information |
Table 85 | :Pherecydes Pharma Business Overview |
Table 86 | :Pherecydes Pharma Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 87 | :Pherecydes Pharma Bacteriophage Product Portfolio |
Table 88 | :Pherecydes Pharma Recent Development |
Table 89 | :APS Biocontrol Ltd. (APS) Company Information |
Table 90 | :APS Biocontrol Ltd. (APS) Business Overview |
Table 91 | :APS Biocontrol Ltd. (APS) Bacteriophage Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 92 | :APS Biocontrol Ltd. (APS) Bacteriophage Product Portfolio |
Table 93 | :APS Biocontrol Ltd. (APS) Recent Development |
Table 94 | :Qingdao Phagepharm Bio-tech Company Information |
Table 95 | :Qingdao Phagepharm Bio-tech Business Overview |
Table 96 | :Qingdao Phagepharm Bio-tech Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 97 | :Qingdao Phagepharm Bio-tech Bacteriophage Product Portfolio |
Table 98 | :Qingdao Phagepharm Bio-tech Recent Development |
Table 99 | :Fixed-Phage Limited Company Information |
Table 100 | :Fixed-Phage Limited Business Overview |
Table 101 | :Fixed-Phage Limited Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 102 | :Fixed-Phage Limited Bacteriophage Product Portfolio |
Table 103 | :Fixed-Phage Limited Recent Development |
Table 104 | :Zeptometrix Company Information |
Table 105 | :Zeptometrix Business Overview |
Table 106 | :Zeptometrix Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 107 | :Zeptometrix Bacteriophage Product Portfolio |
Table 108 | :Zeptometrix Recent Development |
Table 109 | :Phage International, Inc. Company Information |
Table 110 | :Phage International, Inc. Business Overview |
Table 111 | :Phage International, Inc. Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 112 | :Phage International, Inc. Bacteriophage Product Portfolio |
Table 113 | :Phage International, Inc. Recent Development |
Table 114 | :MicroMir Company Information |
Table 115 | :MicroMir Business Overview |
Table 116 | :MicroMir Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 117 | :MicroMir Bacteriophage Product Portfolio |
Table 118 | :MicroMir Recent Development |
Table 119 | :iNtODEWORLD, Inc. Company Information |
Table 120 | :iNtODEWORLD, Inc. Business Overview |
Table 121 | :iNtODEWORLD, Inc. Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 122 | :iNtODEWORLD, Inc. Bacteriophage Product Portfolio |
Table 123 | :iNtODEWORLD, Inc. Recent Development |
Table 124 | :NEXTBIOTICS Company Information |
Table 125 | :NEXTBIOTICS Business Overview |
Table 126 | :NEXTBIOTICS Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 127 | :NEXTBIOTICS Bacteriophage Product Portfolio |
Table 128 | :NEXTBIOTICS Recent Development |
Table 129 | :Armata Pharmaceuticals, Inc. Company Information |
Table 130 | :Armata Pharmaceuticals, Inc. Business Overview |
Table 131 | :Armata Pharmaceuticals, Inc. Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 132 | :Armata Pharmaceuticals, Inc. Bacteriophage Product Portfolio |
Table 133 | :Armata Pharmaceuticals, Inc. Recent Development |
Table 134 | :Innophage Company Information |
Table 135 | :Innophage Business Overview |
Table 136 | :Innophage Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 137 | :Innophage Bacteriophage Product Portfolio |
Table 138 | :Innophage Recent Development |
Table 139 | :Adaptive Phage Therapeutics Company Information |
Table 140 | :Adaptive Phage Therapeutics Business Overview |
Table 141 | :Adaptive Phage Therapeutics Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 142 | :Adaptive Phage Therapeutics Bacteriophage Product Portfolio |
Table 143 | :Adaptive Phage Therapeutics Recent Development |
Table 144 | :TechnoPhage Company Information |
Table 145 | :TechnoPhage Business Overview |
Table 146 | :TechnoPhage Bacteriophage Sales (L), Value (US$ Million), Price (USD/ML) and Gross Margin (2020-2025) |
Table 147 | :TechnoPhage Bacteriophage Product Portfolio |
Table 148 | :TechnoPhage Recent Development |
Table 149 | :Research Programs/Design for This Report |
Table 150 | :Authors List of This Report |
Table 151 | :Secondary Sources |
Table 152 | :Primary Sources |
List of Figures
Figure 1 | :Bacteriophage Product Image |
Figure 2 | :Global Bacteriophage Market Size (US$ Million), 2020 VS 2024 VS 2031 |
Figure 3 | :Global Bacteriophage Market Size (2020-2031) & (US$ Million) |
Figure 4 | :Global Bacteriophage Company Revenue Ranking in 2024 (US$ Million) |
Figure 5 | :Global Top 5 and 10 Company Market Share by Revenue in 2024 (US$ Million) |
Figure 6 | :Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024 |
Figure 7 | :DsDNA Bacteriophage Image |
Figure 8 | :SsDNA Bacteriophage Image |
Figure 9 | :SsRNA Bacteriophage Image |
Figure 10 | :Others Image |
Figure 11 | :Global Bacteriophage Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million) |
Figure 12 | :Global Bacteriophage Sales Value Share 2020 VS 2024 VS 2031 |
Figure 13 | :Global Bacteriophage Sales Value Share by Type (2020-2031) |
Figure 14 | :Animal Health Image |
Figure 15 | :Aquaculture Image |
Figure 16 | :Agriculture Image |
Figure 17 | :Food Industry Image |
Figure 18 | :Human Health Image |
Figure 19 | :Others Image |
Figure 20 | :Global Bacteriophage Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million) |
Figure 21 | :Global Bacteriophage Sales Value Share 2020 VS 2024 VS 2031 |
Figure 22 | :Global Bacteriophage Sales Value Share by Application (2020-2031) |
Figure 23 | :Global Bacteriophage Sales Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Figure 24 | :Global Bacteriophage Sales Value Share by Region: 2020 VS 2024 VS 2031 |
Figure 25 | :North America Bacteriophage Sales Value (2020-2031) & (US$ Million) |
Figure 26 | :North America Bacteriophage Sales Value Share by Country (%), 2024 VS 2031 |
Figure 27 | :Europe Bacteriophage Sales Value (2020-2031) & (US$ Million) |
Figure 28 | :Europe Bacteriophage Sales Value Share by Country (%), 2024 VS 2031 |
Figure 29 | :Asia-Pacific Bacteriophage Sales Value (2020-2031) & (US$ Million) |
Figure 30 | :Asia-Pacific Bacteriophage Sales Value Share by Country (%), 2024 VS 2031 |
Figure 31 | :South America Bacteriophage Sales Value (2020-2031) & (US$ Million) |
Figure 32 | :South America Bacteriophage Sales Value Share by Country (%), 2024 VS 2031 |
Figure 33 | :Middle East & Africa Bacteriophage Sales Value (2020-2031) & (US$ Million) |
Figure 34 | :Middle East & Africa Bacteriophage Sales Value Share by Country (%), 2024 VS 2031 |
Figure 35 | :USA Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 36 | :USA Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 37 | :USA Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 38 | :Canada Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 39 | :Canada Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 40 | :Canada Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 41 | :Mexico Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 42 | :Mexico Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 43 | :Mexico Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 44 | :Germany Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 45 | :Germany Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 46 | :Germany Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 47 | :France Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 48 | :France Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 49 | :France Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 50 | :U.K. Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 51 | :U.K. Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 52 | :U.K. Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 53 | :Italy Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 54 | :Italy Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 55 | :Italy Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 56 | :Spain Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 57 | :Spain Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 58 | :Spain Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 59 | :Russia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 60 | :Russia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 61 | :Russia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 62 | :Netherlands Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 63 | :Netherlands Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 64 | :Netherlands Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 65 | :Nordic Countries Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 66 | :Nordic Countries Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 67 | :Nordic Countries Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 68 | :China Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 69 | :China Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 70 | :China Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 71 | :Japan Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 72 | :Japan Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 73 | :Japan Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 74 | :South Korea Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 75 | :South Korea Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 76 | :South Korea Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 77 | :India Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 78 | :India Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 79 | :India Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 80 | :Australia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 81 | :Australia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 82 | :Australia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 83 | :Southeast Asia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 84 | :Southeast Asia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 85 | :Southeast Asia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 86 | :Brazil Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 87 | :Brazil Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 88 | :Brazil Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 89 | :Argentina Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 90 | :Argentina Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 91 | :Argentina Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 92 | :Chile Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 93 | :Chile Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 94 | :Chile Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 95 | :Colombia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 96 | :Colombia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 97 | :Colombia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 98 | :Peru Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 99 | :Peru Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 100 | :Peru Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 101 | :Saudi Arabia Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 102 | :Saudi Arabia Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 103 | :Saudi Arabia Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 104 | :Israel Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 105 | :Israel Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 106 | :Israel Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 107 | :UAE Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 108 | :UAE Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 109 | :UAE Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 110 | :Turkey Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 111 | :Turkey Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 112 | :Turkey Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 113 | :Iran Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 114 | :Iran Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 115 | :Iran Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 116 | :Egypt Bacteriophage Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 117 | :Egypt Bacteriophage Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 118 | :Egypt Bacteriophage Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 119 | :Years Considered |
Figure 120 | :Research Process |
Figure 121 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Agriculture
Global Bacteriophage Market Outlook and Growth Opportunities 2025
Pages: 214
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.